Public Sector Pension Investment Board (PSP Investments)’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-16,488
Closed -$247K 1313
2016
Q2
$247K Hold
16,488
﹤0.01% 1195
2016
Q1
$201K Hold
16,488
﹤0.01% 1191
2015
Q4
$262K Sell
16,488
-9,800
-37% -$154K ﹤0.01% 1157
2015
Q3
$403K Sell
26,288
-8,900
-25% -$192K ﹤0.01% 1149
2015
Q2
$855K Sell
35,188
-7,500
-18% -$180K 0.01% 1103
2015
Q1
$992K Buy
42,688
+188
+0.4% +$4.98K 0.01% 1090
2014
Q4
$1.07M Hold
42,500
0.01% 1091
2014
Q3
$1.32M Sell
42,500
-4,400
-9% -$119K 0.01% 1007
2014
Q2
$1.21M Buy
+46,900
New +$1.04M 0.01% 1106

Public Sector Pension Investment Board (PSP Investments)'s SGNT Position: Q3 2016 in Review

Public Sector Pension Investment Board (PSP Investments) sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 16,488 shares — an estimated $247K sold.

Public Sector Pension Investment Board (PSP Investments) first reported a position in SGNT in Q2 2014 and held it in 9 quarters. The position peaked at $1.32M in Q3 2014. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

  • Public Sector Pension Investment Board (PSP Investments) reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • Public Sector Pension Investment Board (PSP Investments) sold 16,488 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $247K.
  • Public Sector Pension Investment Board (PSP Investments) first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q2 2014 and held it in 9 quarters.
  • Public Sector Pension Investment Board (PSP Investments)'s SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $1.32M in Q3 2014.
  • 0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on Public Sector Pension Investment Board (PSP Investments)'s 13F filing for Q3 2016, filed 14 Nov 2016.